Published Time：

Just as individuals have their own personalities and temperaments, so do companies.

After more than 20 years of market "trials," Healthy Yuan has cultivated its own unique brand identity—craftsmanship + quality + sentiment. For health, for tomorrow Guided by its mission of "For health, for tomorrow," the group has always adhered to quality, striving to create a healthy ecosystem community of shared destiny.

Today, with the big health industry becoming a strategically important pillar industry that the country highly prioritizes, "Pursuit of Excellence" has undoubtedly become the core support for the company's innovation and sustainable development. Pursuit of Excellence Under a collaborative innovation system that combines "production, education, research, and application," the group has introduced top scientists from home and abroad, conducted in-depth research and strategic planning, continuously increased R&D investment, strictly controlled drug quality, focused on product processes, and actively promoted the industrialization of research results. By the end of 2020, Healthy Yuan had 137 research and development products, with a very rich pipeline reserve.

As a leading domestic inhaler manufacturer, the group has always been committed to seeking technological breakthroughs and has built four high-barrier complex preparation platforms. In recent years, with the gradual realization of R&D results, it has taken the lead in breaking the international market monopoly. At the starting point of the new decade of "Healthy China 2030," it is making every effort to continue its industrial foundation advantages, increase innovation and R&D efforts in key areas, and continuously expand its product lineup and categories. Recently, its diabetes treatment product, Agliletin Benzoic Acid Tablets, was successfully approved as a chemical preparation, providing more high-quality drug options for patients with chronic diseases in China, while also consolidating the group's leading position in scientific research.

Focus, Professionalism, Unrivaled

Innovative R&D and unwavering commitment to quality have become Healthy Yuan's greatest distinguishing features, and the foundation of Healthy Yuan's Unrivaled status.

At a time when the vast majority of China's inhaler market share was occupied by foreign pharmaceutical companies, under the leadership of Chairman Zhu Baoguo, Healthy Yuan, despite facing high R&D and production barriers and the difficulty of imitation, resolutely included inhalers in its core business, clearly focusing on a down-to-earth, dedicated R&D strategic direction, effectively improving medical accessibility and affordability, and benefiting patients with chronic respiratory diseases in China.

Currently, many of Healthy Yuan's respiratory products are 《Chronic Obstructive Pulmonary Disease Diagnosis and Treatment Guidelines ( 2021  Year Revision)》 are listed and recommended, covering all categories of inhaled drugs for chronic obstructive pulmonary disease (COPD), including Lishutong (Salbutamol Hydrochloride Nebulization Solution) ，and " Shutanglin ” (Ipratropium Bromide Compound Inhalation Solution) 、 " Wushu ” (Budesonide Suspension for Inhalation) and other landmark domestically produced generic inhalers, have received recognition from the state and the pharmaceutical industry for their products and technology. With the continuous launch of new products, the group is becoming increasingly stable on its strategic path of "leading domestic inhaler manufacturer."

In addition, Healthy Yuan also pays close attention to cutting-edge technologies and continuously increases the intensity of strategic cooperation. For example, in 2020, the investment in Xinling Pharmaceutical added a layout in the field of transdermal patch technology. In February of this year, Healthy Yuan Research Institute signed a strategic cooperation agreement with Tencent Quantum Laboratory to jointly promote the role of quantum computing + artificial intelligence in the research of microbial synthetic biology and related drugs, contributing to Healthy China 2030.

In the face of changes in the external environment, especially the huge impact of the epidemic, how to maintain stability in the midst of crisis has become a problem that all industries in domestic and international markets must face.

As a rapidly developing and powerful pharmaceutical company, Healthy Yuan, under the mission of For health, For tomorrow has continued to exert efforts in product innovation and R&D, not only minimizing the impact of the epidemic and maintaining stable development across various business segments, but also achieving improvements in employee capabilities, teamwork, and product sales, becoming a successful case of breaking through the challenges in the post-epidemic era for pharmaceutical companies. The greater the difficulty, the more we adhere to our original aspirations and forge ahead.

Since its establishment, the group has always remained true to its original aspirations, constantly surpassing itself, and has won an important award in the capital market at the "2020 Ninth China Listed Companies Summit Forum"— " Most Growing Listed Company in the Big Health Industry ”  Award, and has been listed for many years on the " China's Pharmaceutical Innovation Enterprises 100 Strong ” list, becoming a focus of attention in the pharmaceutical industry and the capital market.

" Healthy China ” is the common vision of the entire Chinese people. Looking at the development of the pharmaceutical industry, from "drug quality is tested" to "drug quality is produced," it has gone through the implementation of the 98 version of GMP, the upgrade of the 2010 version of GMP, and the implementation of the Drug Administration Law in 2019, forming a rigorous attitude in the pharmaceutical industry from a system perspective. For pharmaceutical companies that focus on craftsmanship and quality, this is the best of times.

Originating from sincerity, achieving perfection. The group has always adhered to " For health, for tomorrow mission, carefully making new drugs. Driving high-quality development through innovation, we hope to provide more high-quality domestic drugs for Chinese families through unremitting research, helping people to be healthy, love life, and enjoy life, and using this as a new dimension to explore the company's mission and vision.